Explainer: What strains does the 2014 flu vaccine protect against?

March 17, 2014 by Raina Macintyre
H1N1, one of the flu strains circulating this season, disproportionately affects people aged 24 to 64 years. Credit: fractalworld/Flickr, CC BY-NC

Influenza affects up to 15% of adults and 30% of children each flu season and early indications suggest we could be facing a severe season. The 2014 seasonal influenza vaccination is available from today. So, what strains does it protect against and who should be vaccinated?

What is influenza?

Influenza is a serious viral illness that causes 1,500 to 3,500 deaths in Australia each year from complications such as pneumonia and secondary bacterial infections.

There are two major types in humans – A and influenza B, with the A strain causing more severe disease. Influenza B, however, causes a disproportionate amount of illness in children.

The virus also has many animal hosts including birds, pigs and horses. Genetic mixing between human and animal strains can cause new pandemic strains, to which humans have little or no pre-existing immunity. This susceptibility gives rise to rapid spread, high rates of illness and more severe disease.

Once new strains emerge in humans, they become established as seasonal variants in the population and tend to cycle over the years, with different strains dominating each year. The seasonal flu viruses we see now were once pandemic strains.

Seasonal vaccination

Seasonal influenza viruses mutate continually, so the vaccine needs to be updated annually to match the expected strains.

The commonly used vaccine (trivalent, inactivated influenza vaccine or TIV) covers three strains: two types of influenza A and a single influenza B strain. Protection is strain-specific, so the vaccine will generally only provide good protection against the included strains.

Only 30-40% of people with risk factors get vaccinated each year. Credit: NHSE/Flickr, CC BY

Each year the World Health Organization evaluates the data on circulating viruses and decides on which strains should be covered in the vaccine. Influenza is, however, unpredictable, and sometimes a strain which is not covered in the vaccine can emerge during the .

The 2014 flu vaccine: explainer
Vaccine protection is strain-specific. Credit: Daniel Paquet/Flickr, CC BY

In 2014 the vaccine includes:

  • an A/California/7/2009 (H1N1) pandemic 2009-like strain (similar to swine flu)
  • an A/Texas/50/2012 (H3N2)-like strain
  • and a B/Massachusetts/2/2012-like strain.

Influenza vaccine is an inactivated product, so it cannot cause the flu. The vaccines are safe and effective, although one brand, Fluvax, is not approved for children under the age of five years because of an increased risk of febrile seizures.

There is now a quadrivalent influenza vaccine (QIV) available, which has the same strains as the trivalent plus protection against an additional influenza B strain. There are two major circulating lineages of influenza B, and research shows that the TIV matches the circulating B strain only 50% of the time. As such, the QIV offers greater protection against influenza B.

Should I get vaccinated?

The government recommends – and funds – the influenza vaccination for all people aged 65 years and older, Aboriginal and Torres Strait Islander people aged 15 years or older, pregnant women and anyone over six months of age with a medical condition that predisposes to complications of influenza.

These conditions include heart disease, respiratory disease, chronic illnesses including diabetes, kidney disease, asthma, immunosuppression and chronic neurological conditions. Children on long-term aspirin therapy should also be vaccinated.

Pneumonia is a common complication of influenza, so people in these at-risk groups, along with infants and over-65s, are also recommended to have the pneumococcal vaccine.

The rates of influenza vaccination for people aged 65 years and over are high, but people aged less than 65 years with medical risk factors are less likely to be vaccinated. Only 30-50% of people with risk factors get vaccinated each year.

Research shows the can also protect against heart attacks. Given that ischaemic heart disease is the leading cause of illness and death in the world, the impact of influenza in preventing heart attacks could be significant on a population level.

The 2014 flu season

We often see the strain that dominated in the northern hemisphere in December-January appear in our winter. The major circulating strain in the United States this past winter was the pandemic H1N1 (swine flu) strain, which has a different pattern to usual seasonal influenza, in that it affects people aged 24 to 64 years more than people at the extremes of age.

Usually, other strains of seasonal influenza affect the extremes of age most – the very young and the very old. Others who are more at risk with the pandemic H1N1 are pregnant women, people who are obese, and Aboriginal and Torres Strait Islander people.

Flu seasons typically cycle between mild and severe epidemic years. The last severe influenza season in Australia was in 2009, the year of the pandemic swine flu, and we've have had mild to moderate flu seasons since.

This, coupled with the fact we've had an early start to the flu season in 2014 (with higher case numbers compared to the same time in previous years) suggests we could have a severe season in 2014.

Anyone in the groups recommended for vaccination on the National Immunisation Program schedule should get vaccinated as soon as possible.

Explore further: There's still time to get a flu shot

Related Stories

There's still time to get a flu shot

February 5, 2014
(HealthDay)—It's still not too late to get a flu shot, the U.S. Food and Drug Administration said Wednesday.

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

First vaccine against four flu strains ready to ship

August 6, 2013
(HealthDay)—The U.S Food and Drug Administration has approved shipping of the first vaccine to protect against four strains of seasonal flu.

CDC: Child care flu vaccination requirements seem effective

March 8, 2014
(HealthDay)—Requiring the flu vaccination for child care admission seems to have increased vaccination rates and led to lower hospitalization rates for influenza in young children, according to a report published in the ...

Take kids to get their flu shots early, experts say

September 2, 2013
(HealthDay)—As soon as the updated seasonal flu vaccine becomes available, parents should bring children aged 6 months and older to get vaccinated, according to an updated policy statement from the American Academy of Pediatrics ...

Four works better than three: An enhanced flu vaccine does the trick

April 4, 2012
An intranasal vaccine that includes four weakened strains of influenza could do a better job in protecting children from the flu than current vaccines, Saint Louis University research shows.

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.